RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
130 hedge funds and large institutions have $732M invested in Revance Therapeutics, Inc. in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 21 closing their positions.
Holders
130
Holders Change
-4
Holders Change %
-2.99%
% of All Funds
2.87%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
52
Reduced
38
Closed
21
Calls
$1.66M
Puts
$869K
Net Calls
+$791K
Net Calls Change
+$1.23M
Top Buyers
| 1 |
1
Jennison Associates
New York
|
$25.2M |
| 2 |
2
Goldman Sachs
New York
|
$10.8M |
| 3 |
PAI
3
Palo Alto Investors
Palo Alto,
California
|
$9.11M |
| 4 |
4
BlackRock
New York
|
$59.3M |
| 5 |
5
AllianceBernstein
Nashville,
Tennessee
|
$32.7M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CFGS
152
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
HT
153
HAP Trading
New York
| – | – | – | – |
|
|
VCM
154
Versant Capital Management
Phoenix,
Arizona
| $0 | 12 | +12 | New |
|